Video Experimental Relacionado
Updated: Jul 15, 2026
05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Equilibrar el costo y el beneficio en el tratamiento del cáncer avanzado
Lancet (London, England)
|March 12, 1988
Resumen
Los profesionales de la salud pueden manejar el aumento de los costos médicos mediante la integración de presupuestos clínicos y la selección de tratamientos rentables. Este enfoque asegura una atención adecuada del cáncer y una asignación de recursos justificable para condiciones similares de los pacientes.
Área de la Ciencia:
- Economía de la salud economía de la salud.
- Ética médica La ética médica es la ética médica.
- Oncología Oncología.
Sus antecedentes:
- Las naciones desarrolladas se enfrentan a una escalada de los gastos sanitarios en intervenciones médicas de alta tecnología.
- La falta de discurso público sobre el racionamiento de recursos complica la contención de costos.
- Los médicos actualmente carecen de directrices estandarizadas para la toma de decisiones clínicas conscientes de los costos.
Objetivo del estudio:
- Proponer un marco para que los profesionales de la salud puedan gestionar los crecientes costos de atención médica.
- Abogar por el presupuesto clínico y la selección de tratamientos de costo apropiado en el manejo del cáncer.
- Abordar las consideraciones éticas de la asignación de recursos en la práctica médica.
Principales métodos:
- Presupuesto clínico dirigido por el médico.
- Selección de tratamientos clínicamente apropiados basados en las necesidades individuales del paciente.
- Análisis de las variaciones de costos en el tratamiento de cohortes de pacientes similares.
Principales resultados:
- Los médicos pueden regular los gastos a través de una cuidadosa presupuestación clínica.
- La selección de tratamientos rentables asegura una atención adecuada para los pacientes con cáncer.
- Reducir las disparidades de costos entre los médicos que tratan afecciones similares es alcanzable.
Conclusiones:
- Los profesionales de la salud pueden implementar soluciones a corto plazo para controlar el gasto en atención médica.
- La integración de consideraciones de costos en las decisiones clínicas es esencial para una atención médica sostenible.
- Los organismos profesionales y las revistas médicas apoyan la necesidad de concienciación sobre los costos en la práctica médica.
Palabras clave:
Atención médica y salud pública.Videos de Conceptos Relacionados
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...